Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Atrivita ApS
APS
Active
CVR 42734233
Herlev Hovedgade 195A
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2021
3 employees
https://atrivita.com/
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 389K
-36% vs 2023
EBITDA margin
100.0%
-36% vs 2023
Equity ratio
62.0%
Financial strength
Net profit 2024
DKK 291K
-38% vs 2023
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2022
1M
+100%
2023
0M
-100%
2024
Key figures
Annual report 2024
Revenue
DKK 389K
-36%
EBITDA
DKK 389K
-36%
Net profit
DKK 291K
-38%
Total assets
DKK 1,4M
-12%
Equity
DKK 859K
+51%
Employees
3
—
Company information
Legal name
Atrivita ApS
CVR number
42734233
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
28. september 2021
Share capital
DKK 40.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør.
Company purpose
Selskabets formål er at drive engroshandel med private label-produkter til apotekskæder samt hermed beslægtet virksomhed.
Contact
Address
Herlev Hovedgade 195A
Phone
+4522395608
Email
info@atrivita.com
Website
https://atrivita.com/
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Herlev
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2022
1M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2022
1M
2023
0M
2024
Income statement
DKK thousands
Item
2022
2023
2024
Revenue
78
607
389
Staff expenses
-0
-0
-0
EBITDA
78
607
389
Depreciation & amort.
-0
-0
-0
EBIT
78
607
389
Net financials
-1
-5
-12
Profit before tax
76
602
377
Tax
17
133
86
Net profit
59
469
291
Balance sheet
DKK thousands
Item
2022
2023
2024
Total assets
404
1.570
1.387
Equity
99
568
859
Long-term debt
261
264
0
Short-term debt
44
738
527
Total debt
305
1.002
527
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2022
2024
Equity ratio
62.0%
This company
38.2%
Market median
+62% vs market
2022
2024
Return on equity
33.9%
This company
18.4%
Market median
+84% vs market
2022
2024
Net profit margin
74.7%
This company
8.1%
Market median
+822% vs market
2022
2024
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
2022
2024
Debt / equity
0.61×
This company
0.62×
Market median
+2% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-09-28 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
PW
Perry Wayne Childs
Founder
Founder
2021
—
—
BT
Bo Tandrup
Chief Executive Officer
Chief Executive Officer
2021
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
London Pharma Capital Limited
Individual
50.0%
50.0%
2023
COMMERCE PHARMA HOLDING ApS
Company
33.3%
33.3%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Atrivita ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Perry Wayne Childs
Founder
0 companies
Bo Tandrup
Chief Executive Officer
0 companies